A Phase 2 Study of INCB57643 (BET Inhibitor) in Combination With Ruxolitinib in JAK Inhibitor-naïve Patients With Myelofibrosis
Clinical trial NCT06619522 · WITHDRAWN
Trial details
- NCT number
- NCT06619522
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-11
- Primary completion
- 2025-05-09
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.